Hester Biosciences Ltd.

HESTERBIO

Market Cap
₹2,728 Cr.
P/E
144.41

Hester Biosciences Ltd.

Price
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked
FAQs on Hester Biosciences Ltd. Shareprice

Hester Biosciences has given lower returns compared to its competitors.
Hester Biosciences has grown at ~20.43% over the last 2yrs while peers have grown at a median rate of 24.56%

Yes, Hester Biosciences is expensive.
Latest PE of Hester Biosciences is 144, while 3 year average PE is 53.65.
Also latest EV/EBITDA of Hester Biosciences is 55.01 while 3yr average is 31.22.

GROWTH TABLE
  • Hester Biosciences Ltd.
  • Venkys India
  • NGL Fine-Chem
BALANCE SHEET
  • Hester Biosciences Ltd.
  • Venkys India
  • NGL Fine-Chem
Balance Sheet Snapshot
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
*Data is as of latest FY end
Profit & Loss
  • Hester Biosciences Ltd.
  • Venkys India
  • NGL Fine-Chem
CASH FLOW
  • Hester Biosciences Ltd.
  • Venkys India
  • NGL Fine-Chem
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
Ratios
= Dominant Factor
  • Hester Biosciences Ltd.
  • Venkys India
  • NGL Fine-Chem
Quarterly Results
  • Hester Biosciences Ltd.
  • Venkys India
  • NGL Fine-Chem
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
timeline Timeline
watchlist Watchlist
portfolio Portfolio
alerts Alerts
filter Research
filter Filter
markets Market
raw materials Raw Material
FAQs on Hester Biosciences Ltd. Financials

Balance sheet of Hester Biosciences is strong.
But short term working capital might become an issue for this company.

The debt of Hester Biosciences is decreasing.
Latest debt of Hester Biosciences is ₹224 Crs as of Mar-24.
This is less than Mar-23 when it was ₹239 Crs.

No, profit is decreasing.
The profit of Hester Biosciences is ₹16.56 Crs for TTM, ₹26.63 Crs for Mar 2023 and ₹39.32 Crs for Mar 2022.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hester Biosciences latest dividend payout ratio is 25.56% and 3yr average dividend payout ratio is 23.97%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

Data feed provided by Accord Fintech